CANNABIS SCIENCE INC 
By January 10, 2012
NEWPORT BEACH, Calif. /PRNewswire/ -- On December 21, 2011 Cannabis Science, Inc. (OTCBB:CBIS.OB) reported many critical ailments of which the Company has identified as part of its ongoing mission to capture the market share. One of which is Cancer with estimated Global drug sales growth at a compounded annual rate of 12 to 15 percent, reaching $75 to $80 billion by 2012. Conservatively speaking, if the Company is able to capture only 1% (one percent) of the Cancer market, it would translate to approximately $75 (seventy five) million in that segment alone.
If these figures are on the low-end spectrum then the Company's Earnings Guidance on December 29, 2011 could be well under-estimated since their 2012 forecasted only $6,846,000 and potentially $65,740,000 by 2014. It's a bit early to tell if the Company is able to hit these numbers but judging from their earlier successes from recent case studies, the Company is on the right path to accomplish its goals and maybe more.
Evidently, on two separate press releases, the Company reported its brand extracts successful Cancer treatments as reported by Squamous Cell Carcinoma and Skin Cancer self-medicating patients with continued shrinking of Cancer cells.
According to the testimonials, these patients have photo-documented dramatic results that the Company will release to the public once treatment is completed and has been properly vetted by clinical biopsy. The Company, in conjunction with several Colorado -licensed dispensaries and physicians, consults with a number of cancer patients who were seeking to inform themselves of the current peer-reviewed scientific literature, regarding modern and historical use of cannabis preparations for treating cancers so that they can make informed decisions regarding their self-directed cancer treatment.
Cannabis Science went on to mention that it's making cannabis-based medicines available to the public as rapidly as possible. The Company is taking multiple approaches to accomplishing this aim in the United States . The science of cannabinoids has exploded over the past decade, laying the scientific foundation for the many medicinal uses of this unique plant. Cannabinoids are a class of biologically active compounds produced by all vertebrates (endocannabinoids) the Cannabis plant (phytocannabinoids), and more recently patentable synthetic compounds produced by chemists. Today's modern peer-reviewed science supports the many historical uses that were discovered over thousands of years of medicinal use by herbalists.
Also, the Company has already released its first two Cannabis Science Brand Formulations, Cannabis Science CT-1 and Cannabis Science MT-1. Both are now available at both Cannabis Therapeutics and Marisol Therapeutics exclusively for Colorado State licensed medical marijuana patients.
Cannabis Science MT-1: Produced by Marisol Therapeutics: A family-owned shop, Marisol Therapeutics was founded to assist medical marijuana patients in obtaining medical marijuana in Colorado . They believe patients have the right to safe, confidential, quality medical marijuana and products. They recommend medical marijuana from their own experience with unrelenting and previously untreatable pain. "We understand, we care, we want you to heal." Marisal Therapeutics has produced a custom blend of that is derived from their proprietary strains that were developed over 30 years by a Native American Vietnam veteran in order to address his medical needs. Cannabis Science CT-1 has been analyzed and shown to be free of insecticides and molds. The product is produced in soil under organic roof conditions.
ADDRESS: 922 Kimble Drive, Pueblo West, CO 81007
PHONE: 719-547-4000
| distribué par | Ce noodl a été diffusé par Cannabis Science Inc. et initialement mise en ligne sur le site http://www.cannabisscience.com. La version originale est disponible ici. Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2012-01-11 19:28:54 PM et restera accessible depuis ce lien permanent. Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité. |
